Insider filing · MPLT
Christopher A. Kroeger
Chief Executive Officer
profile →
MapLight Therapeutics, Inc.
MPLT · Healthcare · 30 filings in 24 months
ticker →
Christopher A. Kroeger sold $454K of MapLight Therapeutics (MPLT)
Executed Apr 15, disclosed Apr 17, 2 days later.
Value, as filed
$454K
16,710 sh across 2 lots
Executed
Apr 15
the trade date, as filed
Disclosed
Apr 17
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CKChristopher A. Kroeger (Chief Executive Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in MapLight Therapeutics, Inc. (MPLT). The largest single filing was $5.4M of MPLT (147,457 sh across 5 lots, as filed), executed Jul 15.
The name
MPLTHealthcare · MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Christopher A. Kroeger in MPLT
MPLTSALE
MapLight Therapeutics, Inc.
$5.4M147,457 sh across 5 lots
Exec Jul 15
Filed Jul 17 · 9:46 PM ET MPLTSALE MapLight Therapeutics, Inc. $3.2M
118,037 sh × $27.19
Exec May 18
Filed May 18 · 5:30 PM ET MPLTSALE MapLight Therapeutics, Inc. $1.8M
62,485 sh across 5 lots
Exec May 7
Filed May 11 · 5:30 PM ET MPLTSALE MapLight Therapeutics, Inc. $1.4M
47,808 sh across 5 lots
Exec May 4
Filed May 6 · 5:30 PM ET